Tenet Healthcare Secures $1.9B Payment, Full Conifer Ownership, and Strong 2025 EBITDA Outlook
THC sits 70% above its 52-week low of $109.824.
Summary
Tenet Healthcare announced a strategic transaction with CommonSpirit Health, securing $1.9 billion in payments and full ownership of its Conifer Health Solutions subsidiary, alongside a strong preliminary Adjusted EBITDA outlook for 2025.
Key Events · M&A and Partnerships · THC
-
Strategic Transaction with CommonSpirit Health
Tenet entered an Omnibus Agreement to regain full ownership of its Conifer Health Solutions subsidiary from CommonSpirit Health.
-
Significant Cash Inflow
CommonSpirit Health will pay Tenet approximately $1.9 billion in installments over the next three years, with $540 million already satisfied via offset.
-
Balance Sheet Strengthening
The transaction results in an $885 million reduction in Tenet's redeemable non-controlling interest and other liabilities, and a $305 million increase to additional paid-in capital.
-
Strong Preliminary 2025 Financials
The company expects its Adjusted EBITDA for the year ended December 31, 2025, to be at the upper end of its current guidance range of $4.47 billion to $4.57 billion.
Analysis · THC · Industrial Applications And Services
This 8-K details two highly significant developments for Tenet Healthcare. The company has entered into an Omnibus Agreement with CommonSpirit Health, which will result in CommonSpirit paying Tenet approximately $1.9 billion over three years. This transaction also involves Tenet regaining full ownership of its Conifer Health Solutions subsidiary by redeeming CommonSpirit's 23.8% equity interest, simplifying its corporate structure and providing greater strategic flexibility for Conifer's future investments in technology. The deal significantly strengthens Tenet's balance sheet by reducing liabilities by $885 million and increasing paid-in capital by $305 million. Concurrently, Tenet provided a positive preliminary update for its 2025 financial performance, expecting Adjusted EBITDA to reach the upper end of its guidance range, signaling robust operational execution. Investors should view these developments as a substantial positive, enhancing financial liquidity, strategic control, and demonstrating strong underlying business performance.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 41.2% of the 374 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.38%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, THC was trading at $186.65 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $16.6B. The 52-week trading range was $109.82 to $222.82. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.